Phacoemulsification Cataract Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Phacoemulsification — commonly called phaco or simply "cataract surgery" — is the standard operation to remove a cloudy lens (cataract) from your eye and replace it with a clear artificial lens called an intraocular lens (IOL). It is one of the safest and most commonly performed operations in the world, with approximately 400,000 procedures carried out each year in the UK alone and over 19 million globally.

The word phacoemulsification comes from the Greek phakos (lens) and the Latin emulsify (to break into tiny particles). During the procedure, a surgeon uses a very fine probe — thinner than a pen — that vibrates at ultrasonic speed to gently break up the cloudy lens into tiny fragments. These fragments are then safely washed and vacuumed out of the eye. A soft, foldable artificial lens is then rolled up, inserted through the same tiny opening, and unfolded inside the eye in the exact position your natural lens occupied.

The operation is typically performed awake, using only anaesthetic eye drops. Most people feel pressure or mild vibrations during the operation but no pain. The eye is usually numb within 1–2 minutes of the drops being applied. The entire procedure takes 15–25 minutes and is done as a day case — you go home the same day, usually within 2–3 hours of arrival at the clinic.

Many patients notice an improvement in their vision within hours of surgery, and the eye continues to settle and clear over the following days to weeks. Cataract surgery has one of the highest patient satisfaction rates of any surgical procedure performed today.

A cataract develops when the clear crystalline lens inside your eye becomes progressively cloudy, usually as a result of ageing. Early cataracts can often be managed with stronger spectacle prescriptions, but surgery becomes necessary when the cataract begins to significantly affect daily life.

Common signs that your cataract may be ready for surgery include:

• Blurred or misty vision that cannot be corrected with glasses or contact lenses
• Increased sensitivity to glare — bright sunlight, headlights at night, or indoor lighting causes discomfort or haloes
• Difficulty driving, particularly at night or in low-light conditions
• Faded or yellowed colours — colours appear washed out or less vivid
• Double vision in one eye (monocular diplopia) due to the irregular light scattering through the cloudy lens
• Frequent prescription changes — your glasses prescription keeps changing, sometimes causing a temporary improvement in near vision ("second sight") as the cataract progresses
• Difficulty reading, even with the correct reading glasses

Your ophthalmologist will assess your cataract severity (graded on scales such as LOCS III) and measure your best corrected visual acuity (BCVA). Surgery is typically recommended when your BCVA falls below 6/9 on the Snellen chart, or when functional impairment significantly affects your quality of life — even if the measured acuity appears reasonable.

There is no "too early" or "too late" rule — the right time for surgery is when the cataract is meaningfully affecting your daily activities and you feel ready to proceed.

The vast majority of people with cataracts are suitable for phacoemulsification under topical anaesthesia. Your eye surgeon will assess the following to ensure you are the right candidate:

• General health: Phaco is a brief, minimally invasive procedure under local anaesthetic (eye drops only) and does not require general anaesthesia. It is safe for most elderly patients, including those with heart disease, diabetes, or who take blood thinners. You can generally take all your regular medications on the day of surgery without interruption.
• Eye health — what helps eligibility: A visually significant cataract on slit-lamp examination, healthy retina and optic nerve (assessed by dilated fundus examination), and sufficient corneal health. Patients with well-controlled glaucoma, mild diabetic retinopathy, or previous laser refractive surgery (LASIK, PRK) can usually still have phacoemulsification safely.
• Eye health — what may affect planning: Very small pupils (which can occur with certain prostate medications like tamsulosin) require special techniques. Patients with corneal disease (Fuchs endothelial dystrophy), very dense "mature" white cataracts, or weak lens-supporting ligaments (pseudoexfoliation) may need modified surgical planning but can still usually be safely operated upon by an experienced surgeon.
• Pre-operative measurements: Before surgery, your surgeon will measure the length of your eye and the curvature of your cornea using a non-contact laser device (optical biometry). These precise measurements allow the correct IOL power to be calculated so your eye focuses correctly after surgery — usually targeting clear distance vision without glasses.

If you take anticoagulants (warfarin, aspirin, clopidogrel, or newer blood thinners), these do not need to be stopped for topical phacoemulsification. Always inform your surgeon of all medications, including over-the-counter remedies, before surgery.

The most important decision you will make before cataract surgery is choosing your replacement lens. Your ophthalmologist will guide you, but understanding the main options will help you make an informed choice:

• Monofocal IOL (standard lens): The most commonly used lens. Provides excellent, sharp vision at one distance — usually set for distance (driving, TV, outdoor activities). You will need reading glasses for near tasks such as phones and books. NHS-funded cataract surgery typically includes a standard monofocal IOL. Offers the best contrast sensitivity and minimal optical side effects.
• Toric IOL (astigmatism-correcting lens): A monofocal lens with an additional correction built in to address corneal astigmatism — a condition where the cornea is oval-shaped rather than spherical, causing blurring at all distances. If you have astigmatism and currently wear toric contact lenses or have cylinders in your glasses prescription, a toric IOL may give you sharper uncorrected distance vision. An additional cost applies in private settings; typically not NHS-funded.
• Multifocal IOL (presbyopia-correcting lens): A premium lens that splits light into multiple focal points, allowing vision at distance, intermediate (computer), and near (reading) without glasses. Achieves spectacle independence in 80–90% of patients. A neuroadaptation period of 3–6 months is normal, during which halos around lights at night are common. Premium IOL cost is not covered by NHS — patients pay the upgrade privately.
• Extended depth of focus (EDOF) IOL: Provides a continuous range of clear vision from distance to intermediate with fewer halos than multifocal IOLs. Near vision (very close reading) may still need mild glasses. A good compromise for patients who are bothered by night glare but want good computer vision.

There is no single "best" IOL — the right choice depends on your lifestyle, visual priorities, and willingness to accept trade-offs between spectacle independence and optical side effects.

Phacoemulsification offers life-changing benefits for most patients:

• Rapid vision restoration: Many patients notice clearer, brighter vision within hours of surgery. Full recovery — with vision reaching its final stable level — typically occurs within 4–6 weeks, though most improvement is apparent within the first week.
• Colours become more vivid: The ageing lens yellows progressively, filtering out blue light. After cataract removal, the world often appears dramatically brighter and colours — blues in particular — become remarkably vivid.
• Day-case procedure: No hospital admission is required. You arrive at the clinic, have the operation (15–25 minutes), recover for 30–60 minutes, and go home. A friend or family member should drive you home from the clinic.
• Comfortable procedure: Topical anaesthetic eye drops numb the eye completely. The eye is held open gently with a soft clip. You may see flashing lights or colours during the operation — this is normal. Most patients describe the experience as much easier than they anticipated.
• High success rate: Over 95% of patients without pre-existing eye disease achieve a meaningful improvement in vision. Approximately 85% achieve driving-standard vision (6/12 or better) without glasses if a distance monofocal IOL is selected.
• One operation, lifelong result: The artificial IOL does not cloud over and does not need replacing. It lasts a lifetime. Although posterior capsule opacification (a secondary "after-cataract") can cause blurring in some patients 1–5 years later, this is treated quickly and painlessly with a 5-minute laser procedure.

Phacoemulsification is very safe, but like all surgical procedures, it carries a small risk of complications. Most complications are minor and treatable:

• Posterior capsule opacification (PCO) — "secondary cataract": The most common long-term issue, affecting 10–30% of patients within 2–3 years. A thin film forms on the membrane (capsule) behind the IOL, causing blurring similar to the original cataract. Treatment is simple: a 5-minute in-clinic YAG laser procedure (YAG capsulotomy) permanently clears the membrane painlessly, with no incision or anaesthetic injection required.
• Raised eye pressure (IOP): Temporary increase in pressure inside the eye during the first 24 hours occurs in 10–15% of patients, usually due to residual gel used during surgery. Managed with pressure-lowering eye drops if needed and monitored at your day-1 check.
• Posterior capsule rupture (PCR): The membrane supporting the new lens can occasionally tear during surgery (1–2% of cases). The surgeon will manage this carefully during the operation. A small proportion of PCR cases require additional procedures. Vision outcomes are generally still good with expert management.
• Infection (endophthalmitis): Serious intraocular infection is rare (less than 1 in 1,000 with modern prophylaxis) but constitutes a surgical emergency. Antibiotic eye drops are prescribed post-operatively to minimise risk. If your eye becomes severely red, painful, and vision dramatically worsens in the first 1–2 weeks, contact your surgeon immediately.
• Residual prescription: The IOL power calculation is highly accurate but not perfect. A small proportion of patients are left slightly short-sighted, long-sighted, or astigmatic after surgery and may require glasses for some tasks or, rarely, laser fine-tuning.

Contact your surgeon immediately if you notice sudden worsening of vision, severe eye pain, floaters, or a curtain across your vision at any point after surgery.

Recovery from phacoemulsification is typically straightforward. Here is what to expect:

• Day of surgery: You will wear a protective eye shield on the operated eye overnight. Vision may be slightly hazy initially — this is normal. Rest at home and avoid bending, lifting, or straining.
• Day 1 review: Your surgeon or optometrist will examine your eye the following morning to check healing, measure pressure, and confirm the IOL is in perfect position. Most patients report a clear improvement in vision by this appointment.
• Driving: You may drive when the eye has settled sufficiently and you meet the legal driving standard (reading a number plate at 20 metres). Most patients are able to drive 24–48 hours after surgery on the first eye, and immediately after the second eye procedure (since the first eye will have already recovered).
• Work return: Desk or computer work: most patients return within 1–3 days. Manual or physically demanding work: 1–2 weeks.
• Eye drops: You will be prescribed a course of antibiotic drops (2 weeks) and anti-inflammatory drops (4–6 weeks). These must be used exactly as directed. Do not stop early even if the eye feels comfortable.
• Activity restrictions:
  • Avoid swimming and hot tubs for 4 weeks
  • Avoid eye make-up for 2 weeks
  • Avoid heavy lifting (>10 kg) for 1 week
  • Avoid rubbing the eye at all times
  • Sunglasses recommended outdoors for the first 2–4 weeks
• Second eye: If both eyes need surgery, the second eye is usually scheduled 2–4 weeks after the first, once the first eye has healed and vision has stabilised.

The cost of cataract surgery varies substantially depending on the healthcare system, country, and IOL choice:

• NHS (United Kingdom — free at point of care): If your cataract meets clinical criteria for NHS surgery (BCVA below 6/12 or significant functional impairment), the operation is fully funded. The NHS provides a standard monofocal IOL at no charge. Waiting times currently range from 3 to 18 months depending on region and urgency. Premium IOL upgrades (toric, multifocal, EDOF) are not NHS-funded and must be paid privately — even at NHS hospitals.
• Private UK clinics: Private cataract surgery with standard monofocal IOL costs approximately £2,500–£3,500 per eye (bilateral: £4,500–£6,500). With toric IOL: £3,000–£4,500 per eye. With PanOptix trifocal: £3,500–£5,500 per eye. Advantages include shorter waiting times (usually 1–3 weeks) and choice of surgeon and clinic.
• USA: Medicare covers standard phaco. Private-pay patients without insurance face costs of USD 3,500–6,000 per eye for standard monofocal; up to USD 8,000 per eye for premium multifocal IOL with FLACS.
• Medical tourism (India, Thailand, Turkey): High-volume JCI/NABH-accredited cataract centres offer phaco with monofocal IOL from USD 400–800 per eye, and with PanOptix trifocal from USD 1,000–2,000 per eye. Comprehensive packages including pre-operative assessment, surgery, IOL, and post-operative review are available.
• Key cost considerations: Ask whether the quoted price includes the pre-operative biometry, the IOL itself, post-operative drops, and the day-1 review appointment — some clinics quote procedure costs only and charge separately for these essentials.

Surgery is the only effective cure for a cataract — there are no eye drops, vitamins, or medicines that can clear a cloudy lens or reverse cataract progression. However, surgery can often be safely delayed if the cataract is mild and not significantly affecting daily life:

• Updated spectacle prescription: In early cataracts, the change in lens shape can alter your refractive error. An updated glasses or contact lens prescription may improve functional vision temporarily. This is a reasonable short-term measure while you decide about surgery.
• Anti-glare measures: Anti-reflective coating on spectacle lenses, tinted lenses for bright conditions, and polarised driving glasses can reduce glare symptoms from early cataracts.
• Lifestyle modifications: Increasing reading light intensity, using large-print books or phone display settings, and avoiding night driving until surgery is arranged are pragmatic adaptations.
• Watchful waiting: If your vision meets the legal driving standard and your daily activities are not significantly impaired, you may choose to delay surgery. Your ophthalmologist will monitor the cataract at annual or biannual reviews. There is no evidence that delaying surgery when symptoms are mild causes any long-term harm.
• Dietary antioxidants: While some epidemiological studies suggest associations between diet rich in lutein, zeaxanthin, and vitamins C and E with reduced cataract risk, no clinical trial has shown that supplements slow established cataract progression.

The right time to have surgery is when you feel the cataract is limiting your quality of life and you are ready to proceed. Your surgeon will not pressure you — the decision is yours, informed by the clinical evidence and your own priorities.